Pancreatic cancer patients with a high expression of TCF7L2 have a poorer prognosis than those with low expression levels, and the underlying mechanism is that TCF7L2 positively regulates aerobic glycolysis through the EGLN2/HIF‐1α axis.17 Here, TCF7L2 is linked to familial pancreatic carcinoma.